| Literature DB >> 35377267 |
David M Keller1, Isis G Perez1.
Abstract
MicroRNA-375 (miR-375) is upregulated in the islets of some diabetics and is correlated with poor outcome. Previous work in our laboratory showed that cyclic adenosine monophosphate (cAMP) reduces miR-375 expression and could provide a way to restore normal miR-375 levels, however the transcription repression mechanism is unknown. Using a chromatin immunoprecipitation assay we show that cAMP response element modulator (CREM) binds to the miR-375 promoter 3-fold above background and we find that CREM represses transcription from the miR-375 promoter 1.8-fold. While investigating miR-375 target genes we discovered that several microRNA:mRNA target prediction algorithms listed human CREM as a target gene of miR-375. The predicted binding site is conserved in primates but not in other species. We found that indeed miR-375 binds to the predicted site on human CREM and represses translation of a green fluorescent protein reporter gene by 30%. These findings suggest a primate-specific double-negative feedback loop, a mechanism that would keep these important β-cell regulators in check.Entities:
Keywords: CREM; miR-375; microRNA; transcription; ββcells
Mesh:
Substances:
Year: 2022 PMID: 35377267 PMCID: PMC8986308 DOI: 10.1080/19382014.2022.2060688
Source DB: PubMed Journal: Islets ISSN: 1938-2014 Impact factor: 2.694